2nd International Conference on Fostering Interdisciplinary Research In Health Sciences (ICFIRHS) 2019 (01-May-2019)        |

Journal :   Research Journal of Pharmacy and Technology

Volume No. :   1

Issue No. :  4

Year :  2008

Pages :   426-429

ISSN Print :  0974-3618

ISSN Online :  0974-360X


Allready Registrered
Click to Login

Formulation and Evaluation of Sustained Release System for an Effective Management of Motion Sickness

Address:   Radke RS1 , Gangane PS1 , Kawtikwar PS2* and Rai Sudish3
1I.B.S.S.B’S. College of Pharmacy, Malkapur, Dist. Buldhana-443101. (MS)
2S.N.Institute of Pharmacy, Pusad, Dist. Yeotmal-445204 (MS).
3School Pharmacy, Chouksey Engineering College, Bilaspur- 495001(CG).
*Corresponding Author

Cinnarizine is the most effective drug for management of motion sickness which is selective calcium antagonist inhibiting the influx of calcium itracellularly. Cinnarizine pellets were prepared by powder-layering technique, using Cinnarizine as active ingredient and Eudragit RS-100, Eudragit RL-100, Ethyl cellulose as coating agent, with propylene glycol as plasticizers and PVPK-30 as binder. Drug content was estimated spectrophotometrically at 254 nm. The prepared pellets were further evaluated for surface texture by scanning electron microscopy, uniformity of diameter, thickness and weight, invitro drug release pattern and short-term stability. Pellets coated with 10% Eudragit RS-100 showed promising results releasing more than 95% of drug up to 12 hours. This study concluded that the powder layering technique can be used for designing sustained release drug delivery systems providing drug release over a period of 12 hours.
Cinnarizine, powder-layering technique, Eudragit RS-100, Eudragit RL-100.
Radke RS, Gangane PS, Kawtikwar PS, Rai Sudish. Formulation and Evaluation of Sustained Release System for an Effective Management of Motion Sickness. Research J. Pharm. and Tech. 1(4): Oct.-Dec. 2008;Page 426-429.
[View HTML]      [View PDF]

Visitor's No. :   644312